GE Can't Escape $5M Omniscan Verdict, 6th Circ. Says

Law360, San Francisco (October 20, 2014, 6:03 PM EDT) -- The Sixth Circuit rejected GE Healthcare Inc.'s bid for a new trial Monday, finding that an Ohio court didn't err after a jury ordered GE to pay $5 million for failing to warn a kidney patient about the health risks of  its gadolinium-based contrast agent, Omniscan.

The appeals panel rejected all of GE's arguments in favor of a new trial, including its contention that U.S. District Judge Dan Aaron Polster was required to recuse himself from Paul and Karen Decker's entire case — not just the patient's motion for prejudgment interest — because of his firsthand knowledge of the parties' settlement...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!